Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AvevoRx is a national independent specialty pharmacy that provides personalized care and infusion services for patients with complex, chronic conditions. The company specializes in home infusion therapies for rare and orphan diseases, including immunoglobulin (IVIG/SCIG) treatments, factor replacement therapy for hemophilia, and therapies for Alpha-1 antitrypsin deficiency. AvevoRx utilizes a high-touch clinical model to coordinate care between patients, providers, and payers, ensuring seamless access to life-altering medications. Headquartered in North Carolina, the organization focuses on improving patient outcomes through dedicated clinical support and comprehensive insurance navigation services. By prioritizing patient advocacy and clinical excellence, AvevoRx serves as a critical link in the healthcare continuum for those requiring specialized medication management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AvevoRx.